Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...

Dr. Sohrab Shah's group co-led a multi-institution study into the early genetic origins of breast cancer. Researchers at the ...

Learn about MSK’s active surveillance program for papillary thyroid cancer, which allows many people to avoid unnecessary surgery and the risks that come with it.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Hematologic oncologist Eytan Stein (shown here with nurse practitioner Coleen Ranaghan) has led the development of several new drugs for acute myeloid leukemia. Acute myeloid leukemia (AML) is one of ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Friday, December 6, 2024 - 1:30 p.m. to 2:30 p.m.

The intestinal immune system faces a number of unique challenges due to continuous exposure to rapidly changing exogenous factors including diet and intestinal microbes. Proper calibration of ...

Monday, December 9, 2024 - 10:00 a.m. to 11:00 a.m.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.